What is Emergent Biosolutions's revenue?

Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.

Is Emergent Biosolutions profitable?

Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.

What are Emergent Biosolutions's profit margins?

Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.

What is Emergent Biosolutions's earnings per share?

Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.

Where does Emergent Biosolutions's income statement data come from?

Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Emergent Biosolutions EBS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$156.1M+5.0%	$148.7M-35.7%	$231.1M+64.0%	$140.9M-36.6%	$222.2M+14.1%
Total cost of revenue	$72M-15.2%	$84.9M-1.2%	$85.9M+28.4%	$66.9M-24.4%	$88.5M-25.0%
Gross profit	$84.1M+31.8%	$63.8M-56.1%	$145.2M+96.2%	$74M-44.7%	$133.7M+74.3%
Gross margin	53.9%+11.0pp	42.9%-19.9pp	62.8%+10.3pp	52.5%-7.7pp	60.2%+20.8pp
Research and development	$10.5M-13.2%	$12.1M-10.4%	$13.5M+8.0%	$12.5M-17.2%	$15.1M+65.9%
Selling, general and administrative	$46.6M-8.8%	$51.1M+31.4%	$38.9M-11.0%	$43.7M-16.6%	$52.4M-13.8%
Total costs & expenses	$145.6M-17.6%	$176.6M+14.2%	$154.6M+11.0%	$139.3M-19.2%	$172.3M-15.6%
Operating income	$10.5M—	——	$76.5M+4,681%	$1.6M-96.8%	$49.9M+625%
Operating margin	6.7%—	——	33.1%+32.0pp	1.1%-21.3pp	22.5%+27.3pp
Interest expense	$11M-25.2%	$14.7M-3.3%	$15.2M+3.4%	$14.7M0.0%	$14.7M-0.7%
Other income (expense), net	$2.9M+113%	-$22.8M-20.6%	-$18.9M-2.7%	-$18.4M-143%	$42.8M+336%
Income before income taxes	$13.4M—	——	$57.6M+443%	-$16.8M-118%	$92.7M+436%
Income tax expense	$6.6M+69.2%	$3.9M-39.1%	$6.4M+233%	-$4.8M-119%	$24.7M+568%
Net income	$6.8M—	——	$51.2M+527%	-$12M-118%	$68M+317%
Net margin	4.4%—	——	22.2%+30.7pp	-8.5%-39.1pp	30.6%+46.7pp
Diluted earnings per share	$0.07—	——	$0.91+514%	-$0.22-118%	$1.19+309%
EBITDA	$34M—	——	$99.9M+298%	$25.1M-66.7%	$75.3M+356%
EBITDA margin	21.8%—	——	43.2%+25.4pp	17.8%-16.1pp	33.9%+25.4pp
EBIT	$10.5M—	——	$76.5M+4,681%	$1.6M-96.8%	$49.9M+625%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Emergent Biosolutions.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's revenue?: Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.
Is Emergent Biosolutions profitable?: Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.
What are Emergent Biosolutions's profit margins?: Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.
What is Emergent Biosolutions's earnings per share?: Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.
Where does Emergent Biosolutions's income statement data come from?: Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.